Lipocalin 2-not only a biomarker: a study of current literature and systematic findings of ongoing clinical trials.

Asaf S, Maqsood F, Jalil J, Sarfraz Z, Sarfraz A, Mustafa S, Ojeda IC

Open source

DOI
10.1007/s12026-022-09352-2
Published
2023 Jun
Container
Immunologic research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12026-022-09352-2,
  title = {Lipocalin 2-not only a biomarker: a study of current literature and systematic findings of ongoing clinical trials.},
  author = {Asaf S and Maqsood F and Jalil J and Sarfraz Z and Sarfraz A and Mustafa S and Ojeda IC},
  year = {2023},
  journal = {Immunologic research},
  doi = {10.1007/s12026-022-09352-2},
  url = {https://doi.org/10.1007/s12026-022-09352-2}
}

RIS

TY  - JOUR
TI  - Lipocalin 2-not only a biomarker: a study of current literature and systematic findings of ongoing clinical trials.
AU  - Asaf S
AU  - Maqsood F
AU  - Jalil J
AU  - Sarfraz Z
AU  - Sarfraz A
AU  - Mustafa S
AU  - Ojeda IC
PY  - 2023
JO  - Immunologic research
DO  - 10.1007/s12026-022-09352-2
UR  - https://doi.org/10.1007/s12026-022-09352-2
ER  - 

APA

S, A., F, M., J, J., Z, S., A, S., S, M., & IC, O. (2023). Lipocalin 2-not only a biomarker: a study of current literature and systematic findings of ongoing clinical trials.. Immunologic research. https://doi.org/10.1007/s12026-022-09352-2

Source records